Deutsche Bank Ag\ Reata Pharmaceuticals Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $666,240 - $886,161	-8,410 Reduced 0.56%	1,486,467 $152 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $81,413 - $245,875	2,639 Added 0.18%	1,494,877 $136 Million
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $10.5 Million - $19.9 Million	472,726 Added 46.37%	1,492,238 $56.7 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $7.54 Million - $14.2 Million	388,639 Added 61.6%	1,019,512 $25.6 Million
Q2 2022 Aug 11, 2022	SELL	$20.71 - $36.5 $39,038 - $68,802	-1,885 Reduced 0.3%	630,873 $19.2 Million
Q1 2022 May 13, 2022	SELL	$24.12 - $39.6 $407,531 - $669,081	-16,896 Reduced 2.6%	632,758 $20.7 Million
Q4 2021 Feb 11, 2022	BUY	$25.61 - $110.96 $12,984 - $56,256	507 Added 0.08%	649,654 $17.1 Million
Q3 2021 Nov 04, 2021	BUY	$100.0 - $143.02 $386,700 - $553,058	3,867 Added 0.6%	649,147 $65.3 Million
Q2 2021 Aug 11, 2021	BUY	$78.27 - $151.29 $2.96 Million - $5.72 Million	37,777 Added 6.22%	645,280 $91.3 Million
Q1 2021 May 13, 2021	BUY	$94.25 - $132.81 $25.7 Million - $36.2 Million	272,925 Added 81.57%	607,503 $60.6 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $1.31 Million - $2.38 Million	12,877 Added 4.0%	334,578 $41.4 Million
Q3 2020 Nov 12, 2020	BUY	$93.53 - $163.34 $2.39 Million - $4.17 Million	25,513 Added 8.61%	321,701 $31.3 Million
Q2 2020 Aug 13, 2020	BUY	$126.3 - $176.56 $4.45 Million - $6.23 Million	35,264 Added 13.52%	296,188 $46.2 Million
Q1 2020 May 14, 2020	SELL	$124.16 - $247.74 $3.78 Million - $7.55 Million	-30,464 Reduced 10.45%	260,924 $37.7 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $16.6 Million - $48.4 Million	222,083 Added 320.44%	291,388 $59.6 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $593,667 - $797,693	8,331 Added 13.66%	69,305 $5.56 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $997,691 - $1.21 Million	-12,837 Reduced 17.39%	60,974 $5.75 Million
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $5.06 Million - $9.93 Million	-97,561 Reduced 56.93%	73,811 $6.31 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $2.33 Million - $3.65 Million	47,713 Added 38.58%	171,372 $9.61 Million
Q3 2018 Dec 21, 2021	BUY	$35.64 - $92.06 $296,738 - $766,491	8,326 Added 7.22%	123,659 $10.1 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $2.76 Million - $7.12 Million	77,358 Added 203.71%	115,333 $9.43 Million
Q2 2018 Apr 21, 2020	BUY	$19.94 - $40.96 $168,592 - $346,316	8,455 Added 28.64%	37,975 $1.33 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $223,786 - $459,694	11,223 Added 61.34%	29,520 $1.03 Million
Q1 2018 Oct 18, 2019	BUY	$20.0 - $30.19 $122,300 - $184,611	6,115 Added 50.2%	18,297 $374,000
Q1 2018 May 15, 2018	SELL	$20.0 - $30.19 $263,340 - $397,511	-13,167 Reduced 51.94%	12,182 $248,000
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $337,394 - $501,345	15,069 Added 146.59%	25,349 $717,000
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $270,261 - $327,726	10,280	10,280 $318,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account